GRAIL
by GRAIL
GRAIL utilizes AI to analyze cell-free DNA (cfDNA) and identify methylation patterns in blood samples, allowing for the early detection of over 50 types of cancer before symptoms appear. Its machine learning models process massive genomic datasets to differentiate healthy DNA from cancerous DNA and pinpoint the cancer's likely tissue of origin.
Transparency Score
Weighted across four pillars · updated May 21, 2026
Vendor Information
Complete information about the vendor/provider of this AI application
EU AI Act Provider Information
Potential Risks
1 considerations identified
Review recommended before use
These considerations are automatically identified based on publicly available information about the vendor and AI catalog data. Actual risks may vary based on your specific use case and implementation.
Get insights into risk by running assessments on this AI application.
Work at GRAIL? Claim this listing to correct or complete the data.
Ready to manage AI applications?
Track, assess, and govern your AI applications with Anove.